• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体质指数是腹腔镜肝癌切除术术后发病率的一个风险因素:一项多中心回顾性研究。

Body mass index is a risk factor for postoperative morbidity after laparoscopic hepatectomy of hepatocellular carcinoma: a multicenter retrospective study.

机构信息

Department of Comprehensive Surgery, Vascular Surgery, Nantong First People's Hospital, Affiliated Hospital 2 of Nantong University, Chongchuan District, 666 Shengli Road, Nantong City, 226014, Jiangsu Province, China.

Department of General Surgery, Nantong Second People's Hospital, 298 Xinhua Road, Gangzha District, Nantong City, 226002, Jiangsu Province, China.

出版信息

J Cancer Res Clin Oncol. 2024 Oct 5;150(10):445. doi: 10.1007/s00432-024-05979-w.

DOI:10.1007/s00432-024-05979-w
PMID:39367929
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11455699/
Abstract

PURPOSE

The aim of this study was to determine whether preoperative body mass index (BMI) was associated with postoperative morbidity after laparoscopic liver resection (LLR) for hepatocellular carcinoma (HCC).

METHODS

A total of three groups of patients were categorized based on preoperative BMI: low-BMI (≤ 18.4 kg/m), normal-BMI (18.5-24.9 kg/m) and high-BMI (≥ 25.0 kg/m). Baseline clinicopathological characteristics, operative variables, and postoperative 30-day mortality and morbidity were recorded and compared among the three groups. The independent risk factors for postoperative morbidity, including surgical site infection (SSI), were identified using univariate and multivariate analyses.

RESULTS

Among 226 included patients, 20 (8.8%), 122 (54%), and 84 (37.2%) patients had low, normal, and high BMI, respectively. There were no significant differences in postoperative 30-day mortality rates in patients with low BMI and high BMI compared with those with normal BMI (5% and 1.2% vs. 0%, P = 0.141 and P = 0.408, respectively). However, postoperative morbidity rates were significantly higher in patients with low BMI and high BMI compared to those with normal BMI (40% and 32.1% vs. 17.2%, P = 0.032 and P = 0.020, respectively). According to multivariate analysis, both low and high BMI were independent risk factors of increased postoperative morbidity (OR: 5.03, 95% CI: 1.02-25.6, P = 0.047, and OR: 4.53, 95% CI: 1.75-12.8, P = 0.003, respectively). Low and high BMI were also identified as independent risk factors of increased postoperative SSI rates (OR: 6.25, 95% CI: 1.60-23.8, P = 0.007, and OR: 2.89, 95% CI: 1.04-8.77, P = 0.047, respectively).

CONCLUSION

A higher incidence of postoperative morbidity including SSI after LLR for HCC was found in low-BMI and high-BMI patients compared to normal-BMI patients.

CLINICAL TRIALS REGISTRATION

Not applicable because this is a retrospective observational study.

摘要

目的

本研究旨在确定术前体重指数(BMI)是否与肝癌患者腹腔镜肝切除(LLR)后的术后发病率相关。

方法

根据术前 BMI 将三组患者分为低 BMI(≤18.4 kg/m)、正常 BMI(18.5-24.9 kg/m)和高 BMI(≥25.0 kg/m)。记录三组患者的基线临床病理特征、手术变量以及术后 30 天死亡率和发病率,并进行比较。采用单因素和多因素分析确定术后发病率(包括手术部位感染(SSI))的独立危险因素。

结果

在 226 名纳入患者中,分别有 20 名(8.8%)、122 名(54%)和 84 名(37.2%)患者的 BMI 较低、正常和较高。低 BMI 和高 BMI 患者的术后 30 天死亡率与正常 BMI 患者相比无显著差异(分别为 5%和 1.2%与 0%,P=0.141 和 P=0.408)。然而,低 BMI 和高 BMI 患者的术后发病率明显高于正常 BMI 患者(分别为 40%和 32.1%与 17.2%,P=0.032 和 P=0.020)。多因素分析显示,低 BMI 和高 BMI 均为术后发病率增加的独立危险因素(OR:5.03,95%CI:1.02-25.6,P=0.047,和 OR:4.53,95%CI:1.75-12.8,P=0.003)。低 BMI 和高 BMI 也被确定为术后 SSI 发生率增加的独立危险因素(OR:6.25,95%CI:1.60-23.8,P=0.007,和 OR:2.89,95%CI:1.04-8.77,P=0.047)。

结论

与正常 BMI 患者相比,肝癌患者腹腔镜肝切除术后低 BMI 和高 BMI 患者的术后发病率较高,包括 SSI。

临床试验注册

不适用,因为这是一项回顾性观察研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386d/11793410/549aabfb2263/432_2024_5979_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386d/11793410/549aabfb2263/432_2024_5979_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/386d/11793410/549aabfb2263/432_2024_5979_Fig1_HTML.jpg

相似文献

1
Body mass index is a risk factor for postoperative morbidity after laparoscopic hepatectomy of hepatocellular carcinoma: a multicenter retrospective study.体质指数是腹腔镜肝癌切除术术后发病率的一个风险因素:一项多中心回顾性研究。
J Cancer Res Clin Oncol. 2024 Oct 5;150(10):445. doi: 10.1007/s00432-024-05979-w.
2
Association between body mass index and postoperative morbidity after liver resection of hepatocellular carcinoma: A multicenter study of 1,324 patients.体重指数与肝细胞癌肝切除术后并发症的关系:一项多中心 1324 例患者的研究。
HPB (Oxford). 2020 Feb;22(2):289-297. doi: 10.1016/j.hpb.2019.06.021. Epub 2019 Aug 9.
3
Impact of postoperative morbidity on the prognosis of patients with hepatocellular carcinoma after laparoscopic liver resection: a multicenter observational study.术后并发症对腹腔镜肝切除术后肝细胞癌患者预后的影响:一项多中心观察性研究
Sci Rep. 2025 Jan 11;15(1):1724. doi: 10.1038/s41598-024-85020-9.
4
Laparoscopic liver resection reduces postoperative infection in patients with hepatocellular carcinoma: a propensity score-based analysis.腹腔镜肝切除术降低肝细胞癌患者术后感染率:基于倾向评分的分析。
Surg Endosc. 2022 Dec;36(12):9194-9203. doi: 10.1007/s00464-022-09403-7. Epub 2022 Jul 15.
5
The impact of body mass index on short-term and long-term surgical outcomes of laparoscopic hepatectomy in liver carcinoma patients: a retrospective study.体重指数对肝癌患者腹腔镜肝切除术近期和远期手术结局的影响:一项回顾性研究。
World J Surg Oncol. 2022 May 10;20(1):150. doi: 10.1186/s12957-022-02614-1.
6
Feasibility and efficacy of repeat laparoscopic liver resection for recurrent hepatocellular carcinoma.重复腹腔镜肝切除术治疗复发性肝细胞癌的可行性和疗效。
Surg Endosc. 2020 Oct;34(10):4574-4581. doi: 10.1007/s00464-019-07246-3. Epub 2019 Dec 18.
7
Long-term and short-term surgical outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma: might laparoscopic approach be better in early HCC?腹腔镜与开腹肝切除术治疗肝细胞癌的长期和短期手术结果:腹腔镜方法在早期 HCC 中是否更好?
Surg Endosc. 2019 Apr;33(4):1131-1139. doi: 10.1007/s00464-018-6372-0. Epub 2018 Jul 24.
8
Long-term perioperative outcomes of pure laparoscopic liver resection versus open liver resection for hepatocellular carcinoma: a retrospective study.纯腹腔镜肝切除术与开腹肝切除术治疗肝细胞癌的长期围手术期结局:一项回顾性研究。
Surg Endosc. 2020 Feb;34(2):796-805. doi: 10.1007/s00464-019-06831-w. Epub 2019 Jun 3.
9
Effect of Preoperative Malnutrition Based on Albumin and BMI on Hepatocellular Carcinoma Surgery and Prediction of Risk Factors of Complications.术前白蛋白和 BMI 营养不良对肝癌手术的影响及并发症危险因素预测。
J Gastrointest Cancer. 2024 Jun;55(2):511-518. doi: 10.1007/s12029-023-01008-0. Epub 2024 Jan 2.
10
Postoperative infectious complications following laparoscopic versus open hepatectomy for hepatocellular carcinoma: a multicenter propensity score analysis of 3876 patients.腹腔镜与开腹肝切除术治疗肝细胞癌术后感染性并发症的多中心倾向评分分析:3876 例患者。
Int J Surg. 2023 Aug 1;109(8):2267-2275. doi: 10.1097/JS9.0000000000000446.

引用本文的文献

1
Impact of underweight status on mortality in sepsis patients: a meta-analysis.体重过轻状态对脓毒症患者死亡率的影响:一项荟萃分析
Front Med (Lausanne). 2025 Feb 6;12:1549709. doi: 10.3389/fmed.2025.1549709. eCollection 2025.
2
Gamma-Glutamyl Transpeptidase to Neutrophil Ratio: Prognostic Indicator for Hepatocellular Carcinoma Patients Post-Curative Resection [Letter].γ-谷氨酰转肽酶与中性粒细胞比值:肝细胞癌患者根治性切除术后的预后指标[信函]
J Hepatocell Carcinoma. 2024 Dec 3;11:2391-2392. doi: 10.2147/JHC.S508062. eCollection 2024.

本文引用的文献

1
Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study.病理学家小组在临床试验中实现 NASH 组织学评分共识的效用:来自 3 期研究的数据。
Hepatol Commun. 2023 Dec 22;8(1). doi: 10.1097/HC9.0000000000000325. eCollection 2024 Jan 1.
2
Perioperative and long-term survival outcomes of laparoscopic versus laparotomic hepatectomy for BCLC stages 0-A hepatocellular carcinoma patients associated with or without microvascular invasion: a multicenter, propensity score matching analysis.腹腔镜与开腹肝切除术治疗伴有或不伴有微血管侵犯的 BCLC 分期 0-A 期肝细胞癌患者的围手术期和长期生存结局:一项多中心、倾向评分匹配分析。
Hepatol Int. 2022 Aug;16(4):892-905. doi: 10.1007/s12072-022-10353-4. Epub 2022 Jun 15.
3
Nutrition and Muscle in Cirrhosis.肝硬化中的营养与肌肉
J Clin Exp Hepatol. 2017 Dec;7(4):340-357. doi: 10.1016/j.jceh.2017.11.001. Epub 2017 Nov 8.
4
Impact of time to surgery in the outcome of patients with liver resection for BCLC 0-A stage hepatocellular carcinoma.手术时机对BCLC 0-A期肝细胞癌肝切除患者预后的影响。
J Hepatol. 2017 Oct 6. doi: 10.1016/j.jhep.2017.09.017.
5
Laparoscopic Liver Resection Is a Feasible Treatment for Patients with Hepatocellular Carcinoma and Portal Hypertension.腹腔镜肝切除术是治疗肝细胞癌合并门静脉高压患者的一种可行方法。
Anticancer Res. 2016 Jul;36(7):3489-97.
6
Propensity score analysis of outcomes following laparoscopic or open liver resection for hepatocellular carcinoma.腹腔镜或开腹肝切除术治疗肝细胞癌的结果的倾向评分分析。
Br J Surg. 2016 Jun;103(7):871-80. doi: 10.1002/bjs.10137. Epub 2016 Mar 31.
7
Comparison of the Outcomes of Patients with Hepatocellular Carcinoma and Portal Hypertension After Liver Resection Versus Radiofrequency Ablation.肝切除与射频消融术后肝细胞癌合并门静脉高压患者的疗效比较
World J Surg. 2016 Jul;40(7):1709-19. doi: 10.1007/s00268-016-3465-6.
8
Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study.倾向评分匹配下腹腔镜与开腹肝切除术治疗肝细胞癌的长期及围手术期结局:一项多机构日本研究
J Hepatobiliary Pancreat Sci. 2015 Oct;22(10):721-7. doi: 10.1002/jhbp.276. Epub 2015 Jul 1.
9
Analysis of prognostic factors for survival after hepatectomy for hepatocellular carcinoma based on a bayesian network.基于贝叶斯网络的肝细胞癌肝切除术后生存预后因素分析
PLoS One. 2015 Mar 31;10(3):e0120805. doi: 10.1371/journal.pone.0120805. eCollection 2015.
10
Liver resection in hepatitis B-related hepatocellular carcinoma: clinical outcomes and safety in overweight and obese patients.乙型肝炎相关肝细胞癌的肝切除术:超重和肥胖患者的临床结局与安全性
PLoS One. 2014 Jun 10;9(6):e99281. doi: 10.1371/journal.pone.0099281. eCollection 2014.